Kidney cancer, Renal cell cancer
Results
Phase 2
This study looked at using everolimus for kidney cancer that has spread to another part of the body.
It was for people who were having surgery to remove the kidney as part of their treatment.
Cancer Research UK supported this trial.
Recruitment start: 1 July 2009
Recruitment end: 19 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Cancer Research UK
NIHR Clinical Research Network: Cancer
Novartis
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/10/047.
Last reviewed: 20 Apr 2022
CRUK internal database number: 6977